These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7198598)

  • 1. Renal sodium handling in cirrhosis.
    Charbon GA
    Gastroenterology; 1982 Feb; 82(2):396-7. PubMed ID: 7198598
    [No Abstract]   [Full Text] [Related]  

  • 2. Natriuretic hormone and the sodium retention of cirrhosis.
    Epstein M
    Gastroenterology; 1981 Aug; 81(2):395-7. PubMed ID: 7239143
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney in chronic liver disease: circulatory abnormalities, renal sodium handling and role of natriuretic peptides.
    Valdivieso A
    Biol Res; 1998; 31(3):291-304. PubMed ID: 9830517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal handling of sodium and water in early chronic liver disease. Evidence for a reduced natriuretic activity of the cirrhotic urinary extracts in rats.
    Naccarato R; Messa P; D'Angelo A; Fabris A; Messa M; Chiaramonte M; Gregolin C; Zanon G
    Gastroenterology; 1981 Aug; 81(2):205-10. PubMed ID: 7239129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of renal sodium handling in cirrhosis. A reappraisal.
    Epstein M
    Am J Nephrol; 1983; 3(6):297-309. PubMed ID: 6359883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sodium and water imbalance in liver cirrhosis. Clinical aspects, pathogenesis and therapeutic consequences].
    Brunkhorst R
    Fortschr Med; 1993 Apr; 111(11):186-7. PubMed ID: 8508995
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of ascites and renal salt retention in cirrhosis.
    Palmer BF
    J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide].
    Gambini G; Fioroni E; Guerra M; Moscatelli A; Valori C
    Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and the natriuretic hormone].
    de Wardener HE
    Bull Acad Natl Med; 1982 Oct 5-26; 166(7):1009-13. PubMed ID: 6220761
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
    Sansoè G; Silvano S; Rosina F; Smedile A; Rizzetto M
    J Intern Med; 2005 Apr; 257(4):358-66. PubMed ID: 15788006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.